Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 3/2014

01-03-2014 | Letter to the Editor

Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome

Authors: Jan Moritz Middeke, Normi Bruck, Stefani Parmentier, Martin Bornhäuser, Johannes Schetelig

Published in: Annals of Hematology | Issue 3/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
3.
Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127(1):3–11, PMID: 15384972CrossRefPubMed
4.
5.
Ueng S (2005) Rasburicase (Elitek): a novel agent for tumor lysis syndrome. Proc (Bayl Univ Med Cent) 18(3):275–279, PMID: 16200184
6.
Kizer N, Martinez E, Powell M (2006) Report of two cases of rasburicase-induced methemoglobinemia. Leuk Lymphoma 47(12):2648–2650, PMID: 17169811CrossRefPubMed
7.
Chaudhari T, McGuire W (2012) Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy. Cochrane Database Syst Rev. (2):CD006817. doi:10.​1002/​14651858.​CD006817.​pub3. PMID: 22786499
Metadata
Title
Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome
Authors
Jan Moritz Middeke
Normi Bruck
Stefani Parmentier
Martin Bornhäuser
Johannes Schetelig
Publication date
01-03-2014
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 3/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1836-8

Other articles of this Issue 3/2014

Annals of Hematology 3/2014 Go to the issue

Original Article

Bcl-2 expression is associated with poor prognosis of solitary plasmacytoma of bone

Original Article

Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma

Original Article

Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia

Letter to the Editor

PET-MRI hybrid imaging in a rare case of B cell lymphoblastic lymphoma with musculoskeletal manifestation

Letter to the Editor

The significance of free light chain measurements in the diagnosis of myelomatous pleural effusion

Letter to the Editor

Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits